THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

AQR CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001167557)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 24,684 Value ($000) $462 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 18,835 Value ($000) $275 Avg Close $12.64 Range $10.82 - $14.87

Q2 2025

Shares 12,249 Value ($000) $135 Avg Close $9.72 Range $7.90 - $11.82

Q1 2025

Shares 11,270 Value ($000) $101 Avg Close $9.31 Range $8.35 - $10.90

Q4 2014

Shares 15,236 Value ($000) $227 Avg Close $17.42 Range $13.11 - $24.06

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	24,684	$462	$16.59	$13.50 - $20.33
Q3 2025	18,835	$275	$12.64	$10.82 - $14.87
Q2 2025	12,249	$135	$9.72	$7.90 - $11.82
Q1 2025	11,270	$101	$9.31	$8.35 - $10.90
Q4 2014	15,236	$227	$17.42	$13.11 - $24.06